Irish Life Investment Managers’s NxStage Medical Inc. NXTM Stock Holding History

Irish Life Investment Managers’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$26.1K	Buy	+1,831	New	+$23K	﹤0.01%	1797

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Irish Life Investment Managers's NXTM Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in NxStage Medical Inc. (NXTM) in Q2 2013: 1,831 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #1797 among its holdings.

118 funds tracked by Wall St. Rank hold NXTM as of Q2 2013.

Irish Life Investment Managers held 1,831 shares of NxStage Medical Inc. worth $26.1K as of Q2 2013.
NxStage Medical Inc. was a new Irish Life Investment Managers position in Q2 2013.
NxStage Medical Inc. made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1797 holding.
118 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.